Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(21):1789; doi:10.1093/jnci/91.21.1789A
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Chappell, J.
Right arrow Articles by Eckstein, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chappell, J.
Right arrow Articles by Eckstein, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 21, 1789A, November 3, 1999
© 1999 Oxford University Press

MEMORANDUM FOR: Science Writers and Editors on the Journal Press List

New Information Helps Women Decide About Taking Tamoxifen to Prevent Breast Cancer

October 28, 1999 (EMBARGOED FOR RELEASE 4 P.M. EST November 2)

Julianne Chappell, Executive Editor, Dan Eckstein, (301) 986-1891, ext. 112

Information that can help women compare the risks and benefits of taking the drug tamoxifen to prevent breast cancer is presented in the November 3 issue of the Journal of the National Cancer Institute.

The information comes from a study by Mitchell Gail, M.D., Ph.D., of the National Cancer Institute, and colleagues. Their work was prompted by findings that, in certain circumstances, women . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?